Abstract
Methadone maintenance treatment was established in New York City in 1964 by Drs. Vincent Dole and Marie Nyswander.1,2 The original treatment regimen implemented by Drs. Dole and Nyswander with their staff provided comprehensive medical and rehabilitative services to intravenous heroin addicts. Criteria for admission included: 4 years of heroin addiction, a history of prior treatment failure, voluntary desire for treatment, age over 19, primary dependence upon opiates, and absence of psychosis or major medical complications. In the initial studies, addicts were evaluated and stabilized on a daily oral dose of methadone on an inpatient service before transfer to an outpatient clinic for continued treatment. With further experience, it was found feasible to eliminate the inpatient phase of treatment and start with the outpatient clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dole VP, Nyswander M (1965) A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 193: 80–84
Dole V (1989) Methadone maintenance. In Courtwright D, Joseph H, Des Jarlais D: Addicts Who Survived: An Oral History of Narcotic Use in America, 1923–1965. Knoxville: University of Tennessee Press, pp 331–343
Dole VP, Nyswander ME, Warner A (1968) Successful treatment of 750 criminal addicts. JAMA 206: 2708–2711
Gearing FR (1972) Methadone maintenance: six years later. Contemp Drug Prob 1: 191–206
Gearing FR (1970) Successes and failures in methadone maintenance treatment of heroin addiction in New York City. In: Proceedings of the Third National Conference on Methadone Treatment. Rockville: US Public Health Service, Pub. No. 2172, pp 2–16
Connell PH (1975) Review of methadone maintenance schemes. In Boström H, Larsson T, Ljungstedt N (eds): Skandia International Symposia: Drug Dependence-Treatment and Treatment Evaluation. Stockholm: Almqvist & Wiksell, pp 133–146
Newman RG, in collaboration with Cates MS (1977) The role of social and psychiatric services. In Methadone Treatment in Narcotic Addiction: Program Management, Findings, and Prospects for the Future. New York: Academic Press, pp 64–68
Lowinson JH (1981) Methadone maintenance in perspective. In Lowinson JH, Ruiz P (eds): Substance Abuse: Clinical Problems and Perspectives. Baltimore: Williams & Wilkins, pp 344–354
D’Amanda C (1983) Program policies and procedures associated with treatment outcome. In Cooper JR, Altman F, Brown BS, Czechowicz D (eds): NIDA Treatment Research Monograph Series: Research on the Treatment of Narcotic Addiction: State of the Art. (ADM) 83–1281. Rockville: US Department of Health and Human Services, pp 637–679
Boume PG (1981) A 10-year perspective on the addiction problem. In Lowinson JH, Ruiz P (eds): Substance Abuse: Clinical Problems and Perspectives. Baltimore: Williams & Wilkins, pp 35–42
Kirn TF (1988) Methadone maintenance treatment remains controversial even after 23 years of experience. JAMA 260: 2970–2975
Gerstein DR, Harwood HJ (eds) (1990) Treating Drug Problems, Vol. 1. Washington, DC: National Academy Press
United States General Accounting Office (1990) Methadone maintenance: some treatment programs are not effective; greater federal oversight needed. In: GAO Report to the Chairman, Select Committee on Narcotics Abuse and Control, House of Representatives (March). Washington, DC: US Government Printing Office
Klepak D (1978) Evaluation of treatment effectiveness: the New York State experience. Ann NY Acad Sci 311: 248–252
FDA, personal communication, January 1989
Butynski W, Canova D, Jensen S (1989) State Resources and Services Related to Alcohol and Drug Abuse Problems—Fiscal Year 1988: An analysis of state alcohol and drug abuse. Washington, DC: National Association of State Alcohol and Drug Abuse Directors
Parrino M (1989) Letter to Bennett WJ
Murphy S, Rosenbaum M (1988) Money for methadone. II. Unintended consequences of limited-duration methadone maintenance. J Psychoactive Drugs 20: 397–402
Des Jarlais DC, Friedman SR (1989) AIDS and the IV drug user. Science 245: 578
Des Jarlais DC, Friedman SR (1987) Target groups for preventing AIDS among intravenous drug users. J Appl Soc Psychol 17: 251–268
Galea RP, Lewis BF, Baker LA (eds) (1988) AIDS and IV Drug Abusers: Current Perspectives. Owings Mills: National Health Publishing, Exhibit I-1, I-2, pp xxvii, xxx-xxxi
Novick DM, Joseph H, Croxson TS, et al (1990) Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med 150: 97–99
Des Jarlais DC (1990) Stages in the response of the drug abuse treatment system to the AIDS epidemic in New York City. J Drug Issues 20: 335–347
Cooper JR, Altman F, Brown B, Czechowicz D (eds) (1983) NIDA Treatment Research Monograph Series: Research on the Treatment of Narcotic Addiction: State of the Art. (ADM) 83–1281. Rockville: US Department of Health and Human Services
Tims FM, Ludford JP (eds) (1984) NIDA Research Monograph 51: RAUS: Drug Abuse Treatment Evaluation: Strategies, Progress, and Prospects. (ADM) 84–1329. Rockville: US Department of Health and Human Services
Hubbard RL, Marsden ME, Rachal JV, et al (1989) Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill: University of North Carolina Press
Simpson DD, Sells SB (eds) (1990) Opioid Addiction and Treatment: a 12-year follow-up. Malabar: Robert E. Krieger Publishing Company
Jaffe JH (1979) The swinging pendulum: the treatment of drug users in America. In Dupont RI, Goldstein A, O’Donnell J (eds): Handbook on Drug Abuse. Washington, DC: US Government Printing Office, pp 3–16
Cooper JR (1989) Methadone treatment and acquired immunodeficiency syndrome. JAMA 262: 1664–1668
Pickens RW, Fletcher BW (1991) Overview of treatment issues. In: Improving Drug Abuse Treatment: NIDA Monograph. In press
Lipton DS, Appel P (1984) The state perspective. In Tims FM, Ludford JP (eds): NIDA Research Monograph Series 51: RAUS: Drug Abuse Treatment Evaluation: Strategies, Progress, and Prospects. (ADM) 84–1329. Rockville: US Department of Health and Human Services, pp 151–166
Hall SM (1983) Methadone treatment: a review of the research findings. In Cooper JR, Altman F, Brown B, Czechowicz D (eds): NIDA Treatment Research Monograph Series: Research on the Treatment of Narcotic Addiction: State of the Art. (ADM) 83–1281. Rockville: US Department of Health and Human Services, pp 575–632
Gottheil E, McLellan AT, Druley KA (eds) (1981) Reasonable and unreasonable methodological standards for the evaluation of alcoholism treatment. In: Matching Patient Needs and Treatment Methods in Alcoholism and Drug Abuse. Springfield: Charles C Thomas, pp 371–389
Altman F, Schnoll SH (1983) Discussion summary. In Cooper JR, Altman F, Brown B, Czechowicz D (eds): NIDA Treatment Research Monograph Series: Research on the Treatment of Narcotic Addiction: State of the Art. (ADM) 83–1281. Rockville: US Department of Health and Human Services, pp 573–574
Hubbard RL, Rachal JV, Craddock SG, Cavanaugh ER (1984) Treatment outcome prospective study (TOPS): client characteristics and behaviors before, during, and after treatment. In: Tims FM, Ludford JP (eds): NIDA Research Monograph Series 51: RAUS Drug Abuse Treatment Evaluation: Strategies, Progress, and Prospects. (ADM) 84–1329. Rockville: US Department of Health and Human Services, pp 42–68
Meyer R (1983) Introduction to part III: factors affecting the outcome of methadone treatment. In Cooper JR, Altman F, Brown B, Czechowicz D (eds): NIDA Treatment Research Monograph Series: Research on the Treatment of Narcotic Addiction: State of the Art. (ADM) 83–1281. Rockville: US Department of Health and Human Services, pp 495–499
Woody GE (1983) Treatment characteristics associated with outcome. In Cooper JR, Altman F, Brown B, Czechowicz D (eds): NIDA Treatment Research Monograph Series: Research on the Treatment of Narcotic Addiction: State of the Art. (ADM) 83–1281. Rockville: US Department of Health and Human Services, pp 541–564
Tonry M (1990) Research on drugs and crime. In Tonry M, Wilson JQ (eds): Drugs and Crime, Vol. 13. Chicago: University of Chicago Press, pp 1–8
Moos RH, Finney JW (1987–1988) Alcoholism program evaluation: the treatment domain. Drugs Society 2: 31–51
Terry CE, Pellens M (1970) The Opium Problem. Montclair, NJ: Patterson Smith
Pescor MJ (1943) A statistical analysis of the clinical records of hospitalized drug addicts. Public Health Rep Suppl 143. Washington, DC: US Government Printing Office, pp 1–30
Second Triennial Report to Congress from the Secretary (1987) Drug Abuse and Drug Abuse Research. DHHS (ADM) 87–1486. Rockville: US Department of Health and Human Services, pp. 59–75
Moos RH, Finney JW, Cronkite RC (eds) (1990) Alcoholism Treatment: Context, Process, and Outcome. New York: Oxford University Press
McLellan AT, Alterman AI, Woody GE (1991) A quantitative measure of substance abuse treatment programs: the treatment services review. J Nery Ment Dis (in press)
Anglin MD, Hser YI (1990) Treatment of drug abuse. In Tonry M, Wilson JQ (eds): Drugs and Crime, pp 393–460
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Ball, J.C., Ross, A. (1991). Status of Methadone Maintenance Treatment and Research in the United States. In: The Effectiveness of Methadone Maintenance Treatment. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9089-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9089-3_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9091-6
Online ISBN: 978-1-4613-9089-3
eBook Packages: Springer Book Archive